Ignite Creation Date:
2024-05-06 @ 2:57 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04474470
Status:
COMPLETED
Last Update Posted:
2024-05-09
First Post:
2020-06-30
Brief Title:
A Study to Evaluate NT219 Alone and in Combination with ERBITUX Cetuximab in Adults with Advanced Solid Tumors and Head and Neck Cancer
Sponsor:
TyrNovo Ltd
Organization:
Purple Biotech Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-03
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-06-30
First Submit QC Date:
July 13 2020
Study First Post Date:
2020-07-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-15
Last Update Post Date:
2024-05-09
Last Update Post Date Type:
ACTUAL